While there is evidence that some ingredients may promote GLP-1 production in the body 8,9 , there is little evidence that these can reduce body fat long-term 10
Missed doses : Follow product-specific guidance
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
Beyond its metabolic functions, GLP-1 is involved in regulating various behaviors, including feeding, fluid intake, and even motivated behaviors like drug consumption
When deciding which GLP-1 providers to feature in our various roundups, Healthlines editors and expert writers including registered dietitians and those with backgrounds in the health and medical fields research each platform to better understand what it offers and who it might be a good fit for
The Sufficiency of Disclosure: Patent law requires an inventor to sufficiently disclose their invention